Helping to Create New Possibilities for People with Primary Biliary Cholangitis (PBC)
![Pill bottles in a manufacturing facility](/-/media/gilead-corporate/images/home/manufaturing-line-1140x641.jpg?la=en&h=1066&w=1892&hash=3CA8D529CF29195D7FBEC0D3673FEB98)
The FDA has granted accelerated approval for a new therapy for PBC, a liver disease that can lead to chronic itch. This development builds on our legacy of innovation in liver disease.
Our Purpose
![A group of people sitting at a table](/-/media/gilead-corporate/images/home/stephaniecox3-min.jpg)
We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.
Our MissionRecent Stories
![Eyepiece of a microscope](/-/media/gilead-corporate/images/home/gilead_home_page_microscope.jpg)
Join Our Team
We're Hiring